Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 5.00
0.00 (0.00%)
May 27, 2026, 10:36 AM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 3.08 billion as of May 27, 2026. Its market cap has decreased by -22.16% in one year.
Market Cap
3.08B
Enterprise Value
3.40B
Revenue
14.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.00
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 3.08B, a decrease of -74.51%. That is a compound annual growth rate of -28.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 3.08B | 25.00% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 3.87B |
| Shandong Boan Biotechnology | 3.73B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.66B |
| BioDlink International Company | 3.53B |
| TYK Medicines | 3.44B |
| Clover Biopharmaceuticals | 3.25B |
| Medtide | 3.05B |